Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Insulin Aspart vs Lispro Beyond 48 Hours in Pumps
NCT00461331Phase 4Completed
- Sponsor
- Tulane University
- Start
- Oct 2004
- Primary completion
- Jun 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in type 1 diabetes mellitus (T1D) comparing Insulin Aspart with Insulin Lispro (2 arms). Primary endpoint: Number of Participants With Glycemic Control (Glucose Levels Between 180-300 mg/dL). Started Oct 2004; status: completed.
02
Drugs
insulin aspartinsulin lispro
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT00461331.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00461331.